home / stock / snpx / snpx quote
Last: | $1.56 |
---|---|
Change Percent: | 15.56% |
Open: | $1.35 |
Close: | $1.56 |
High: | $1.6 |
Low: | $1.27 |
Volume: | 38,601 |
Last Trade Date Time: | 05/18/2021 04:42:35 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.56 | $1.35 | $1.56 | $1.6 | $1.27 | 38,601 | 05-18-2021 |
$1.35 | $1.31 | $1.35 | $1.44 | $1.3 | 6,878 | 05-17-2021 |
$1.28 | $1.46 | $1.28 | $1.46 | $1.25 | 46,712 | 05-14-2021 |
$1.46 | $1.36 | $1.46 | $1.52 | $1.26 | 98,074 | 05-13-2021 |
$1.43 | $1.61 | $1.43 | $1.74 | $1.205 | 252,891 | 05-12-2021 |
$1.66 | $1.74 | $1.66 | $1.75 | $1.58 | 51,204 | 05-11-2021 |
$1.75 | $1.98 | $1.75 | $1.98 | $1.54 | 88,083 | 05-10-2021 |
$2 | $2.01 | $2 | $2.14 | $1.98 | 17,092 | 05-07-2021 |
$2.0299 | $2.08 | $2.0299 | $2.2 | $1.98 | 52,482 | 05-06-2021 |
$2.2801 | $2.33 | $2.2801 | $2.33 | $2.02 | 1,381 | 05-05-2021 |
$2.15 | $2.3 | $2.15 | $2.3 | $2 | 11,119 | 05-04-2021 |
$2.16 | $2.35 | $2.16 | $2.35 | $2.1001 | 44,663 | 05-03-2021 |
$2.39 | $2.4 | $2.39 | $2.7 | $2.2499 | 121,185 | 04-30-2021 |
$2.75 | $2.64 | $2.75 | $2.75 | $2.4 | 21,746 | 04-29-2021 |
$2.7 | $2.57 | $2.7 | $2.78 | $2.52 | 49,020 | 04-28-2021 |
$2.7 | $2.6 | $2.7 | $2.74 | $2.48 | 19,977 | 04-27-2021 |
$2.69 | $2.5 | $2.69 | $2.79 | $2.32 | 20,906 | 04-26-2021 |
$2.5 | $2.5 | $2.5 | $2.5 | $2.4 | 7,729 | 04-23-2021 |
$2.47 | $2.35 | $2.47 | $2.5 | $2.3 | 3,074 | 04-22-2021 |
$2.5 | $2.35 | $2.5 | $2.5 | $2.2 | 12,335 | 04-21-2021 |
News, Short Squeeze, Breakout and More Instantly...
Synaptogenix Inc. Company Name:
SNPX Stock Symbol:
OTCMKTS Market:
Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing PR Newswire NEW YORK , April 24, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company develo...
Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics PR Newswire Supports IP development for novel mushroom genetics and therapeutics for multiple indications NEW YORK , April 9, 202...
Synaptogenix Inc (NASDAQ:SNPX) shares are trading slightly higher Thursday morning after the company announced a 1-for-25 reverse stock split. This...